Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis


Elshafae S. M., Dirksen W. P., Alasonyalilar-Demirer A., Breitbach J., Yuan S., Kantake N., ...Daha Fazla

PROSTATE, cilt.80, sa.9, ss.698-714, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 80 Sayı: 9
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1002/pros.23983
  • Dergi Adı: PROSTATE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, Gender Studies Database, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.698-714
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background Osteoblastic bone metastasis represents the most common complication in men with prostate cancer (PCa). During progression and bone metastasis, PCa cells acquire properties similar to bone cells in a phenomenon called osteomimicry, which promotes their ability to metastasize, proliferate, and survive in the bone microenvironment. The mechanism of osteomimicry resulting in osteoblastic bone metastasis is unclear.